Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sofia Appelberg
Observed names:
Appelberg S,
Appelberg, Sofia,
Appelberg, Sofia K.,
S. Appelberg,
Sofia K. Appelberg
Institution:
Public Health Agency of Sweden
Observed institutions:
Public Health Agency of Sweden,
Karolinska University Hospital,
Karolinska Institutet,
University of Florida
ORCID:
0000-0002-7381-3606
Observed ORCID:
0000-0002-7381-3606
OpenAlex ID:
A5064802887
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
2020
·
Sofia Appelberg
, Soham Gupta
, et al.
·
Emerging Microbes & Infections
·
294
Nucleoside-Modified mRNA Vaccines Protect IFNAR –/– Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
2021
·
Sofia Appelberg
, Lijo John
, et al.
·
Journal of Virology
·
72
Crimean–Congo haemorrhagic fever virus uses LDLR to bind and enter host cells
2024
·
Vanessa M. Monteil
, Shane C. Wright
, et al.
·
Nature Microbiology
·
54
IL2RG hypomorphic mutation: identification of a novel pathogenic mutation in exon 8 and a review of the literature
2019
·
Che Kang Lim
, Hassan Abolhassani
, et al.
·
Allergy Asthma and Clinical Immunology
·
47
PDF
Δ9-Tetrahydrocannabinol Treatment During Human Monocyte Differentiation Reduces Macrophage Susceptibility to HIV-1 Infection
2014
·
Julie C. Williams
, Sofia Appelberg
, et al.
·
Journal of Neuroimmune Pharmacology
·
47
PDF
The SARS-CoV-2 N Protein Is a Good Component in a Vaccine
2020
·
Gustaf Ahlén
, Lars Frelin
, et al.
·
Journal of Virology
·
45
Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model
2022
·
David W. Hawman
, Kimberly Meade-White
, et al.
·
Molecular Therapy
·
41
Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
2022
·
Ujjwal Neogi
, Nazif Elaldi
, et al.
·
eLife
·
40
Subclass-switched anti-spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization
2023
·
Arman Izadi
, Arsema Hailu
, et al.
·
Proceedings of the National Academy of Sciences
·
30
A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells
2022
·
Sofia Appelberg
, Gustaf Ahlén
, et al.
·
EMBO Molecular Medicine
·
26
PDF
The HIV-1 protease inhibitor nelfinavir activates PP2 and inhibits MAPK signaling in macrophages: a pathway to reduce inflammation
2012
·
Mark A Wallet
, Caroline M Reist
, et al.
·
Journal of Leukocyte Biology
·
26
Identification of CCZ1 as an essential lysosomal trafficking regulator in Marburg and Ebola virus infections
2023
·
Vanessa Monteil
, Hyesoo Kwon
, et al.
·
Nature Communications
·
20
PDF
Hazara virus and Crimean-Congo Hemorrhagic Fever Virus show a different pattern of entry in fully-polarized Caco-2 cell line
2020
·
Vanessa Monteil
, Cristiano Salata
, et al.
·
PLoS neglected tropical diseases
·
20
PDF
Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse
2024
·
Amy Flaxman
, Sarah Sebastian
, et al.
·
PLoS Pathogens
·
16
Systems-level temporal immune-metabolic profile in Crimean-Congo hemorrhagic fever virus infection
2023
·
Anoop T. Ambikan
, Nazif Elaldi
, et al.
·
Proceedings of the National Academy of Sciences
·
16
Presence of antibodies to Crimean Congo haemorrhagic fever virus in sheep in Tunisia, North Africa
2021
·
Médiha Khamassi Khbou
, Rihab Romdhane
, et al.
·
Veterinary Medicine and Science
·
10
PDF
Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease
2024
·
Jingyi Yan
, Chandrashekar Ravenna Bangalore
, et al.
·
Molecular Therapy
·
9
PDF
P53-Independent G1-Cell Cycle Arrest Increases SARS-CoV-2 RNA Replication
2024
·
Clara Husser
, Hyesoo Kwon
, et al.
·
Microorganisms
·
4
PDF
Enhanced Seroconversion to West Nile Virus Proteins in Mice by West Nile Kunjin Replicon Virus-like Particles Expressing Glycoproteins from Crimean–Congo Hemorrhagic Fever Virus
2022
·
Pham-Tue-Hung Tran
, Urban Höglund
, et al.
·
Pathogens
·
4
PDF
A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations
2026
·
Soo Aleman
, Gustaf Ahlén
, et al.
·
Molecular Therapy Advances
·
3
The natural polyphenol proanthocyanidin A2 prevents the in vitro infection of Ebola virus and rabies virus by interfering with the early phases of the replication cycle
2025
·
Denis Pasqual
, Ilaria Artusi
, et al.
·
Antiviral Research
·
2
Integrated systems vaccinology reveals distinct metabolic responses to SARS-CoV-2 infection and DNA-based vaccines in ferrets
2025
·
Gustaf Ahlén
, Anoop Ambikan
, et al.
·
Biomedicine & Pharmacotherapy
·
1
Editorial: Tick-borne Bunyaviruses: an emerging public health threat
2025
·
David W. Hawman
, Sofia Appelberg
, et al.
·
Frontiers in Microbiology
·
1
PDF
A randomized dose-escalation phase I clinical trial of a nucleoprotein-based genetic vaccine against Crimean-Congo Hemorrhagic Fever
2026
·
Ali Mirazimi
, christian nordentoft
, et al.
·
Research Square
PDF
Coviretinopathy: COVID-19-induced VEGF-dependent retinopathy
2026
·
Xiaolu Wang
, Xu Jing
, et al.
·
Proceedings of the National Academy of Sciences
Show more works
View as search
Works count:
38
Citation count:
828
H-index:
15
I10-index:
16
Year
Topic
Type